Cytosorbents Corporation provided earnings guidance for the fourth quarter and full year of 2016. For the quarter, the company expects 2016 product sales of approximately $2.6 million (range $2.5 million - $2.7 million), against $1.5 million in fourth quarter 2015, continues six consecutive quarters of record sales, and is up sequentially by more than 20% from third quarter 2016· 2016 blended gross product margins, between higher margin direct sales and lower margin distributor sales, are expected to exceed 65%. For the year, the company expects to announce approximately $8.2 million in full year 2016 CytoSorb sales (range $8.1 million - $8.3 million), a doubling from $4.0 million in 2015.